| 摘要 |
<p>The present invention is concerned with novel spiro-piperidine derivatives as V1a receptor antagonists, their manufacture, pharmaceutical compositions containing them and their use as medicaments. The active compounds of the present invention are useful in the prevention and/or treatment of anxiety and depressive disorders and other diseases. In particular, the present invention is concerned with compounds of the general formula (I), wherein R<sup>1</sup> to R<sup>5</sup>, R<sup>5'</sup>, X, Y and A are as defined in the specification.</p> |
